How Partisan Policies Can Shape Health Behaviors: Executive Order Proof-of-Vaccine Mandate Bans Increased COVID-19 Vaccinations
Abstract
1. Introduction
2. Materials and Methods
2.1. Conceptual Frameworks
2.2. Data and Measures
2.3. Study Sample
2.4. Study Period
2.5. Sample Stratification
2.6. Statistical Analysis
3. Results
4. Discussion
Limitations
5. Conclusions
Supplementary Materials
Author Contributions
Funding
Institutional Review Board Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
Abbreviations
| POV | Proof of Vaccine |
| SEM | Social Ecological Model |
| EFL | Expressive Function of Law |
| PRT | Psychological Reactance Theory |
| GRD | Geographic-Regression Discontinuity |
| TWFEE | Two-Way Fixed-Effects Estimation |
| DiD | Difference-in-Differences |
| HHS | The US Department of Health and Human Services |
| NASHP | National Academy for State Health Policy |
| EO | Executive Order |
| SB | Senate Bill |
| HB | House Bill |
Appendix A
Appendix A.1. Parallel Trends
| Full Sample | Executive Order Sample | Legislative Sample | ||||
|---|---|---|---|---|---|---|
| Coefficient (se) | p-Value | Coefficient (se) | p-Value | Coefficient (se) | p-Value | |
| Variables | ||||||
| Treatment Status | ||||||
| Control (ref) | -- | -- | -- | -- | -- | -- |
| Treatment | −2.1% (8.8%) | 0.82 | −2.46% (12.4%) | 0.085 | −10.3% (10.9%) | 0.35 |
| Time till POV Mandate Ban (in weeks) | −0.1% (0.1%) | 0.92 | 0.8% (1.7%) | 0.63 | 0.7% (0.4%) | 0.13 |
| Treatment Status × Time till POV Mandate Ban (in weeks) | ||||||
| Control × Time = 0 (ref) | -- | -- | -- | -- | -- | -- |
| Treatment × Time | −0.5% (1.3%) | 0.73 | −1.37% (2.7%) | 0.62 | −2.0% (1.4%) | 0.89 |
Appendix A.2. Sample Selection

| Executive Order Sample | Legislative Sample | |||
|---|---|---|---|---|
| Coefficient (se) | p-Value | Coefficient (se) | p-Value | |
| Variables | ||||
| Treatment Counties × post-POV Mandate Ban periods () | ||||
| Pre-period (ref) | -- | -- | -- | -- |
| Weeks 1–2 | 32.6% (12.3%) | 0.022 * | 1.2% (19.6%) | 0.95 |
| Weeks 3–4 | 22.8% (13.1%) | 0.11 | 11.1% (19.9%) | 0.57 |
| Weeks 5–6 | 22.5% (19.2%) | 0.26 | 22.5% (27.2%) | 0.41 |
| Weeks 7–8 | 28.1% (19.8%) | 0.18 | 13.7% (27.6%) | 0.60 |
| Weeks 9–10 | 4.3% (19.7%) | 0.82 | 22.2% (31.6%) | 0.47 |
| Weeks 11–12 | 18.6% (16.6%) | 0.28 | 22.4% (34.4%) | 0.50 |
| GRD Sample | p-Value | Full-County Sample | p-Value | |||
|---|---|---|---|---|---|---|
| Treatment | Control | Treatment | Control | |||
| Trump votes in 2020 (% of county) | 69.6% | 64.5% | <0.001 *** | 69.4% | 60.9% | <0.001 *** |
| Population Size (<65-year-olds; N) | 67,078 | 73,091 | 0.59 | 68,670 | 97,750 | 0.012 * |
| Health Literacy Scores | 243.6 | 244.0 | 0.22 | 242.5 | 244.2 | <0.001 *** |
| Proportion ≥ 65 years old (%) | 18.6% | 18.7% | 0.67 | 18.8% | 18.8% | 0.94 |
| College Degree (%) | 18.3% | 19.2% | 0.006 ** | 18.1% | 20.2% | <0.001 *** |
| Per Capita Income 2019 ($) | $44,692 | $44,818 | 0.79 | $44,367 | $46,250 | <0.001 *** |
Appendix A.3. Study Period
Appendix A.4. Sensitivity Testing
| Executive Order Sample | Legislative Sample | |||
|---|---|---|---|---|
| Coefficient (se) | p-Value | Coefficient (se) | p-Value | |
| Variables | ||||
| Treatment Counties × post-POV Mandate Ban periods () | ||||
| Pre-period (ref) | -- | -- | -- | -- |
| Week 1 | 61.2% (13.5%) | 0.001 ** | −2.0% (14.8%) | 0.90 |
| Week 2 | 18.4% (18.3%) | 0.32 | −9.2% (17.1%) | 0.61 |
| Week 3 | 62.8% (15.4%) | 0.002 ** | −5.6% (14.4%) | 0.71 |
| Week 4 | 17.4% (16.8%) | 0.31 | 13.2% (22.0%) | 0.54 |
| Week 5 | 47.3% (17.8%) | 0.025 * | 28.3% (27.4%) | 0.31 |
| Week 6 | 34.2% (14.2%) | 0.035 * | −9.3% (21.4%) | 0.69 |
| Week 7 | 37.6% (16.6%) | 0.047 * | −8.3% (22.3%) | 0.73 |
| Week 8 | 51.7% (19.6%) | 0.027 * | 17.1% (27.9%) | 0.52 |
| Week 9 | 13.4% (22.5%) | 0.54 | 41.7% (29.4%) | 0.18 |
| Week 10 | 48.2% (19.1%) | 0.032 * | 5.0% (36.1%) | 0.87 |
| Week 11 | 20.9% (15.1%) | 0.19 | 21.6% (33.4%) | 0.50 |
| Week 12 | 43.7% (16.7%) | 0.026 * | 19.8% (32.4%) | 0.52 |
| Executive Order Sample | Legislative Sample | |||
|---|---|---|---|---|
| Coefficient (se) | p-Value | Coefficient (se) | p-Value | |
| Variables | ||||
| Treatment Counties × post-POV Mandate Ban periods () | ||||
| Pre-period (ref) | -- | -- | -- | -- |
| Weeks 1–4 | 39.4% (10.8%) | 0.003 ** | −1.3% (13.3%) | 0.93 |
| Weeks 5–8 | 43.8% (16.1%) | 0.021 * | 5.7% (23.8%) | 0.80 |
| Weeks 9–12 | 28.7% (14.9%) | 0.08 | 20.8% (30.1%) | 0.48 |
| 125 Miles | 100 Miles | 75 Miles | ||||
|---|---|---|---|---|---|---|
| Coefficient (se) | p-Value | Coefficient (se) | p-Value | Coefficient (se) | p-Value | |
| Executive Order POV Mandate Ban States | ||||||
| ) | ||||||
| Weeks 1–2 | 38.9% (10.4%) | 0.002 ** | 36.9% (10.4%) | 0.004 ** | 39.0% (10.3%) | 0.002 ** |
| Weeks 3–4 | 43.8% (12.1%) | 0.003 ** | 43.4% (13.2%) | 0.007 ** | 50.3% (13.1%) | 0.003 ** |
| Weeks 5–6 | 41.6% (17.0%) | 0.035 * | 38.5% (18.6%) | 0.07 | 41.4% (17.8%) | 0.044 * |
| Weeks 7–8 | 48.2% (18.1%) | 0.025 * | 50.6% (19.2%) | 0.027 * | 57.0% (18.1%) | 0.012 * |
| Weeks 9–10 | 40.7% (18.1%) | 0.05 | 34.9% (19.7%) | 0.11 | 44.7% (19.7%) | 0.05 |
| Weeks 11–12 | 47.6% (19.3%) | 0.036 * | 46.7% (21.4%) | 0.06 | 44.6% (19.6%) | 0.049 * |
| Legislative POV Mandate Ban States | ||||||
| ) | ||||||
| Weeks 1–2 | −8.6% (13.8%) | 0.55 | −11.5% (13.3%) | 0.40 | −11.7% (13.0%) | 0.38 |
| Weeks 3–4 | 0.8% (18.1%) | 0.96 | −1.3% (15.1%) | 0.94 | −2.7% (14.4%) | 0.86 |
| Weeks 5–6 | 5.0% (22.9%) | 0.82 | 3.1% (21.9%) | 0.88 | 1.3% (21.3%) | 0.95 |
| Weeks 7–8 | 0.3% (26.5%) | 0.99 | −1.9% (20.6%) | 0.93 | −6.7% (20.9%) | 0.77 |
| Weeks 9–10 | 19.8% (28.7%) | 0.48 | 19.4% (28.1%) | 0.48 | 15.0% (28.5%) | 0.58 |
| Weeks 11–12 | 18.8% (32.0%) | 0.54 | 16.8% (31.4%) | 0.57 | 11.6% (31.7%) | 0.69 |
| 5-Mile Buffer | 10-Mile Buffer | 25-Mile Buffer | ||||
|---|---|---|---|---|---|---|
| Coefficient (se) | p-Value | Coefficient (se) | p-Value | Coefficient (se) | p-Value | |
| Executive Order POV Mandate Ban States | ||||||
| ) | ||||||
| Weeks 1–2 | 38.1% (10.5%) | 0.003 ** | 37.7% (10.2%) | 0.003 ** | 42.3% (10.0%) | 0.001 ** |
| Weeks 3–4 | 40.6% (12.1%) | 0.006 ** | 40.4% (11.7%) | 0.005 ** | 45.9% (12.4%) | 0.003 ** |
| Weeks 5–6 | 41.3% (15.9%) | 0.026 * | 40.4% (15.8%) | 0.028 * | 42.2% (15.9%) | 0.024 * |
| Weeks 7–8 | 43.9% (17.4%) | 0.031 * | 42.6% (17.3%) | 0.034 * | 47.1% (16.6%) | 0.018 * |
| Weeks 9–10 | 30.4% (18.3%) | 0.13 | 28.0% (17.4%) | 0.14 | 30.3% (17.7%) | 0.11 |
| Weeks 11–12 | 32.0% (15.3%) | 0.06 | 32.0% (15.2%) | 0.06 | 33.7% (14.2%) | 0.037 * |
| Legislative POV Mandate Ban States | ||||||
| ) | ||||||
| Weeks 1–2 | −5.6% (14.9%) | 0.72 | −4.2% (15.5%) | 0.80 | 0.4% (20.5%) | 0.98 |
| Weeks 3–4 | 3.5% (19.0%) | 0.85 | 6.4% (18.7%) | 0.72 | 10.4% (21.1%) | 0.61 |
| Weeks 5–6 | 7.8% (24.4%) | 0.73 | 10.3% (24.2%) | 0.65 | 14.3% (27.7%) | 0.59 |
| Weeks 7–8 | 3.7% (27.4%) | 0.88 | 6.5% (27.0%) | 0.79 | 8.8% (28.1%) | 0.74 |
| Weeks 9–10 | 21.6% (30.0%) | 0.46 | 23.8% (29.6%) | 0.42 | 25.9% (31.5%) | 0.40 |
| Weeks 11–12 | 20.7% (32.8%) | 0.51 | 24.7% (32.6%) | 0.44 | 27.2% (33.7%) | 0.41 |
References
- AJMC Staff. A Timeline of COVID-19 Vaccine Developments in 2021. 3 June 2021. Available online: https://www.ajmc.com/view/a-timeline-of-covid-19-vaccine-developments-in-2021 (accessed on 1 March 2022).
- Beleche, T.; Ruhter, J.; Kolbe, A.; Marus, J.; Bush, L.; Sommers, B. COVID-19 Vaccine Hesitancy: Demographic Factors, Geographic Patterns, and Changes over Time; Department of Health and Human Services: Washington, DC, USA, 2021.
- Viswanath, K.; Bekalu, M.; Dhawan, D.; Pinnamaneni, R.; Lang, J.; McLoud, R. Individual and social determinants of COVID-19 vaccine uptake. BMC Public Health 2021, 21, 818. [Google Scholar] [CrossRef]
- Occupational Safety and Health Administration. US Department of Labor Issues Emergency Temporary Standard to Protect Workers from Coronavirus|OSHA. 4 November 2021. Available online: https://www.dol.gov/newsroom/releases/osha/osha20211104 (accessed on 7 February 2024).
- See Where 12 Million U.S. Employees Are Affected by Government Vaccine Mandates. The New York Times, 18 December 2021. Available online: https://www.nytimes.com/interactive/2021/12/18/us/vaccine-mandate-states.html (accessed on 15 February 2022).
- Mzezewa, T. Why You May Soon Need a Digital Vaccine Passport to Travel. The New York Times, 4 February 2021. Available online: https://www.nytimes.com/2021/02/04/travel/coronavirus-vaccine-passports.html (accessed on 18 July 2022).
- The National Academy for State Health Policy. State Efforts to Ban or Enforce COVID-19 Vaccine Mandates and Passports. 4 April 2022. Available online: https://www.nashp.org/state-lawmakers-submit-bills-to-ban-employer-vaccine-mandates/ (accessed on 19 April 2022).
- Karaivanov, A.; Kim, D.; Lu, S.E.; Shigeoka, H. COVID-19 vaccination mandates and vaccine uptake. Nat. Hum. Behav. 2022, 6, 1615–1624. [Google Scholar] [CrossRef]
- Mills, M.C.; Rüttenauer, T. The effect of mandatory COVID-19 certificates on vaccine uptake: Synthetic-control modelling of six countries. Lancet Public Health 2022, 7, e15–e22. [Google Scholar] [CrossRef]
- Wang, Y.; Stoecker, C.; Callison, K.; Hernandez, J.H. State COVID-19 vaccine mandates and uptake among health care workers in the US. JAMA Netw. Open 2024, 7, e2426847. [Google Scholar] [CrossRef] [PubMed]
- Latkin, C.; Dayton, L.A.; Yi, G.; Konstantopoulos, A.; Park, J.; Maulsby, C.; Kong, X. COVID-19 vaccine intentions in the United States, a social-ecological framework. Vaccine 2021, 39, 2288–2294. [Google Scholar] [CrossRef]
- Dillard, J.P.; Tian, X.; Cruz, S.M.; Smith, R.A.; Shen, L. Persuasive messages, social norms, and reactance: A study of masking behavior during a COVID-19 campus health campaign. Health Commun. 2023, 38, 1338–1348. [Google Scholar] [CrossRef]
- Sprengholz, P.; Felgendreff, L.; Böhm, R.; Betsch, C. Vaccination policy reactance: Predictors, consequences, and countermeasures. J. Health Psychol. 2022, 27, 1394–1407. [Google Scholar] [CrossRef] [PubMed]
- Ball, H.; Wozniak, T.R. Why do some Americans resist COVID-19 prevention behavior? an analysis of issue importance, message fatigue, and reactance regarding COVID-19 messaging. Health Commun. 2021, 37, 1812–1819. [Google Scholar] [CrossRef] [PubMed]
- Brehm, S.S.; Brehm, J.W. Psychological Reactance: A Theory of Freedom and Control; Academic Press: San Diego, CA, USA, 2013. [Google Scholar]
- Schmelz, K.; Bowles, S. Opposition to voluntary and mandated COVID-19 vaccination as a dynamic process: Evidence and policy implications of changing beliefs. Proc. Natl. Acad. Sci. USA 2022, 119, 13. [Google Scholar] [CrossRef]
- Kriss, L.A.; Quick, B.L.; Rains, S.A.; Barbati, J.L. Psychological reactance theory and COVID-19 vaccine mandates: The roles of threat magnitude and direction of threat. J. Health Commun. 2022, 27, 654–663. [Google Scholar] [CrossRef]
- Grandpre, J.; Alvaro, E.M.; Burgoon, M.; Miller, C.H.; Hall, J.R. Adolescent reactance and anti-smoking campaigns: A theoretical approach. Health Commun. 2003, 15, 349–366. [Google Scholar] [CrossRef] [PubMed]
- Miller, C.H.; Lane, L.T.; Deatrick, L.M.; Young, A.M.; Potts, K.A. Psychological reactance and promotional health messages: The effects of controlling language, lexical concreteness, and the restoration of freedom. Hum. Commun. Res. 2007, 33, 219–240. [Google Scholar] [CrossRef]
- Geana, M.V.; Rabb, N.; Sloman, S. Walking the party line: The growing role of political ideology in shaping health behavior in the United States. SSM-Popul. Health 2021, 16, 100950. [Google Scholar]
- Findling, M.G.; Blendon, R.J.; Benson, J.M. Polarized Public Opinion About Public Health During the COVID-19 Pandemic: Political Divides and Future Implications. In Proceedings of the JAMA Health Forum; American Medical Association: Chicago, IL, USA, 2022; Volume 3, p. e220016. [Google Scholar]
- Chan, E.Y.; Lin, J. Political ideology and psychological reactance: How serious should climate change be? Clim. Change 2022, 172, 17. [Google Scholar] [CrossRef]
- Sunstein, C.R. On the expressive function of law. Univ. Pa. Law Rev. 1996, 144, 2021–2053. [Google Scholar] [CrossRef]
- Fine, P.E.M.; Clarkson, J.A. Individual versus public priorities in the determination of optimal vaccination policies. Am. J. Epidemiol. 1986, 124, 6. [Google Scholar]
- Mazzei, P.; Stolberg, S.G.; Sullivan, E.; Paz, I.G. Florida’s Governor Bans Agencies and Businesses from Requiring ‘Vaccine Passports’. The New York Times, 2 April 2021. Available online: https://www.nytimes.com/2021/04/02/us/florida-vaccine-passport-desantis.html (accessed on 19 April 2022).
- Treisman, R. Some States Are Working to Prevent COVID-19 Vaccine Mandates. National Public Radio, 2 August 2021. Available online: https://www.npr.org/2021/08/02/1023809875/states-ban-covid-vaccine-mandates (accessed on 25 April 2022).
- Weinberg, T. Missouri Businesses Oppose Ban on COVID Vaccine Mandates, Argue it’s Their Choice. Missouri Independent, 12 January 2022. Available online: https://missouriindependent.com/2022/01/12/missouri-business-oppose-covid-vaccine-mandate-ban/ (accessed on 10 March 2022).
- Bessarabova, E.; Fink, E.L.; Turner, M. Reactance, restoration, and cognitive structure: Comparative statics. Hum. Commun. Res. 2013, 39, 339–364. [Google Scholar] [CrossRef]
- Centers for Disease Control and Prevention. COVID-19 Vaccinations in the United States, County|Data. 12 May 2022. Available online: https://data.cdc.gov/Vaccinations/COVID-19-Vaccinations-in-the-United-States-County/8xkx-amqh/about_data (accessed on 12 May 2022).
- CSSE TC for SS and E at JHU. COVID-19 Data Repository. Published Online 18 August 2020. Available online: https://github.com/CSSEGISandData/COVID-19 (accessed on 12 May 2022).
- Census Bureau Data. Available online: https://data.census.gov/ (accessed on 7 January 2025).
- Vaccine Hesitancy for COVID-19. Available online: https://data.cdc.gov/stories/s/Vaccine-Hesitancy-for-COVID-19/cnd2-a6zw/ (accessed on 7 January 2025).
- HHS (The U.S. Department of Health and Human Services). COVID-19 State and County Policy Orders. Published Online 25 July 2023. Available online: https://catalog-old.data.gov/dataset/covid-19-state-and-county-policy-orders-9408a/resource/1f029561-28a9-432c-98f9-efcfc7a1e9ac (accessed on 25 September 2023).
- Alvarez-Zuzek, L.G.; Zipfel, C.M.; Bansal, S. Spatial clustering in vaccination hesitancy: The role of social influence and social selection. PLoS Comput. Biol. 2022, 18, e1010437. [Google Scholar] [CrossRef]
- Mano, R.C. Mask Mandates Save Lives. IMF Work. Pap. 2021, 205, 205. [Google Scholar] [CrossRef]
- Keele, L.J.; Titiunik, R. Geographic boundaries as regression discontinuities. Political Anal. 2015, 23, 127–155. [Google Scholar]
- Goodman-Bacon, A. Difference-in-differences with variation in treatment timing. J. Econom. 2021, 225, 2. [Google Scholar] [CrossRef]
- Weissert, C.S.; Uttermark, M.J.; Mackie, K.R.; Artiles, A. Governors in Control: Executive Orders, State-Local Preemption, and the COVID-19 Pandemic. Publius 2021, 51, 3. [Google Scholar] [CrossRef]
- Sun, L.; Abraham, S. Estimating dynamic treatment effects in event studies with heterogeneous treatment effects. J. Econom. 2021, 225, 175–199. [Google Scholar] [CrossRef]
- Hughes, B.; Miller-Idriss, C.; Piltch-Loeb, R.; Goldberg, B.; White, K.; Criezis, M.; Savoia, E. Development of a codebook of online anti-vaccination rhetoric to manage COVID-19 vaccine misinformation. Int. J. Environ. Res. Public Health 2021, 18, 7556. [Google Scholar] [CrossRef]
- Alberts, C.J.; Clifford, G.M.; Georges, D.; Negro, F.; Lesi, O.A.; Hutin, Y.J.; de Martel, C. Worldwide prevalence of hepatitis B virus and hepatitis C virus among patients with cirrhosis at country, region, and global levels: A systematic review. Lancet Gastroenterol. Hepatol. 2022, 7, 724–735. [Google Scholar] [CrossRef] [PubMed]
- Rains, S.A.; Richards, A.S. US state vaccine mandates did not influence COVID-19 vaccination rates but reduced uptake of COVID-19 boosters and flu vaccines compared to bans on vaccine restrictions. Proc. Natl. Acad. Sci. USA 2024, 121, e2313610121. [Google Scholar] [CrossRef] [PubMed]
- Stone, W. RFK Jr. Names New Slate of Vaccine Advisers After Purging CDC Panel. National Public Radio, 12 June 2025. Available online: https://www.npr.org/sections/shots-health-news/2025/06/11/nx-s1-5430870/cdc-vaccine-experts-rfk-jr (accessed on 18 June 2025).
- Desilver, D. States Have Mandated Vaccinations Since Long Before COVID-19. Pew Research Center. 9 May 2022. Available online: https://www.pewresearch.org/short-reads/2021/10/08/states-have-mandated-vaccinations-since-long-before-covid-19/ (accessed on 9 May 2022).
- Li, L.; Wood, C.E.; Kostkova, P. Vaccine hesitancy and behavior change theory-based social media interventions: A systematic review. Transl. Behav. Med. 2022, 12, 2. [Google Scholar] [CrossRef]
- Desilver, D. The Polarization in Today’s Congress Has Roots that Go Back Decades. Pew Research Center. 9 November 2022. Available online: https://www.pewresearch.org/short-reads/2022/03/10/the-polarization-in-todays-congress-has-roots-that-go-back-decades/ (accessed on 9 November 2022).
- Kerr, J.; Panagopoulos, C.; Van Der Linden, S. Political polarization on COVID-19 pandemic response in the United States. Personal. Individ. Differ. 2021, 179, 110892. [Google Scholar] [CrossRef]
- Biden, J.R. National Strategy for the COVID-19 Response and Pandemic Preparedness: January 2021; Simon and Schuster: New York, NY, USA, 2021. [Google Scholar]



| State | Enactment Date | Policy Mechanism |
|---|---|---|
| Utah (UT) | 16 March 2021 | HB a 308 |
| Florida (FL) | 2 April 2021 | EO b 2021-81 |
| Texas (TX) | 5 April 2021 | EO GA-35 |
| Idaho (ID) | 7 April 2021 | EO 2021-04 |
| Montana (MT) | 13 April 2021 | EO 7-2021 |
| Arizona (AZ) | 19 April 2021 | EO 2021-09 |
| South Dakota (SD) | 20 April 2021 | EO 2021-08 |
| Alaska (AK) c | 26 April 2021 | AO d 321 |
| Indiana (IN) | 29 April 2021 | HB 1405 |
| Arkansas (AR) | 30 April 2021 | SB e 615 |
| North Dakota (ND) | 7 May 2021 | HB 1465 |
| Wyoming (WY) | 7 May 2021 | EO |
| South Carolina (SC) | 11 May 2021 | EO 2021-23 |
| Alabama (AL) | 17 May 2021 | SB 267 |
| Iowa (IA) | 20 May 2021 | HF f 889 |
| Georgia(GA) | 25 May 2021 | EO 5.25.21.01 |
| Kansas (KS) | 26 May 2021 | SB 159 |
| Tennessee (TN) | 26 May 2021 | SB 858 |
| Oklahoma (OK) | 1 June 2021 | EO 2021-16 |
| Missouri (MO) | 15 June 2021 | HB 271 |
| New Hampshire (NH) | 23 July 2021 | HB 220 |
| Michigan (MI) | 29 September 2021 | SB 82 |
| Full Sample | Executive Order Sample | Legislative Sample | ||||
|---|---|---|---|---|---|---|
| Coefficient (se) | p-Value | Coefficient (se) | p-Value | Coefficient (se) | p-Value | |
| Variables | ||||||
| Treatment Counties × post-POV Mandate Ban periods () | ||||||
| Pre-period (ref) | -- | -- | -- | -- | ||
| Weeks 1–2 | 10.2% (12.5%) | 0.42 | 38.2% (10.5%) | 0.003 ** | −5.7% (14.7%) | 0.71 |
| Weeks 3–4 | 16.7% (12.4%) | 0.19 | 40.6% (12.2%) | 0.006 ** | 3.3% (18.9%) | 0.85 |
| Weeks 5–6 | 16.8% (16.8%) | 0.32 | 41.3% (16.0%) | 0.027 * | 7.8% (24.3%) | 0.73 |
| Weeks 7–8 | 14.5% (19.7%) | 0.46 | 43.9% (17.3%) | 0.030 * | 3.5% (27.2%) | 0.89 |
| Weeks 9–10 | 25.1% (23.0%) | 0.29 | 30.2% (18.3%) | 0.13 | 21.5% (29.7%) | 0.46 |
| Weeks 11–12 | 21.2% (25.2%) | 0.40 | 31.9% (15.2%) | 0.06 | 20.4% (32.5%) | 0.51 |
| % of County Voting for Trump 2020 | ||||
|---|---|---|---|---|
| ≤69.6% | >69.6% | |||
| Coefficient (se) | p-Value | Coefficient (se) | p-Value | |
| Treatment Counties × post-POV Mandate Ban periods () | ||||
| Pre-period (ref) | -- | -- | -- | -- |
| Weeks 1–2 | 35.1% (16.3%) | 0.06 | 44.8% (9.9%) | 0.001 ** |
| Weeks 3–4 | 43.0% (14.4%) | 0.013 * | 45.7% (12.4%) | 0.003 ** |
| Weeks 5–6 | 41.8% (17.1%) | 0.035 * | 49.1% (14.9%) | 0.008 ** |
| Weeks 7–8 | 41.4% (21.0%) | 0.08 | 51.9% (14.7%) | 0.005 ** |
| Weeks 9–10 | 55.5% (27.4%) | 0.08 | 20.6% (10.7%) | 0.08 |
| Weeks 11–12 | 38.5% (22.2%) | 0.12 | 29.8% (12.0%) | 0.029 * |
| % of County with College Degree | ||||
| ≤18.4% | >18.4% | |||
| Coefficient (se) | p-value | Coefficient (se) | p-value | |
| Treatment Counties × post-POV Mandate Ban () | ||||
| Pre-period (ref) | -- | -- | -- | -- |
| Weeks 1–2 | 29.1% (9.5%) | 0.009 ** | 51.7% (13.6%) | 0.003 ** |
| Weeks 3–4 | 45.8% (11.4%) | 0.002 ** | 29.3% (15.2%) | 0.08 |
| Weeks 5–6 | 55.7% (15.3%) | 0.004 ** | 22.2% (18.5%) | 0.25 |
| Weeks 7–8 | 53.5% (16.0%) | 0.007 ** | 27.1% (21.0%) | 0.22 |
| Weeks 9–10 | 38.1% (18.4%) | 0.07 | 18.7% (22.9%) | 0.41 |
| Weeks 11–12 | 43.9% (17.8%) | 0.034 * | 15.9% (15.0%) | 0.30 |
| % of County Uninsured | ||||
| ≤13.7% | >13.7% | |||
| Coefficient (se) | p-value | Coefficient (se) | p-value | |
| Treatment Counties × post-POV Mandate Ban periods () | ||||
| Pre-period (ref) | -- | -- | -- | -- |
| Weeks 1–2 | 15.7% (12.5%) | 0.23 | 54.2% (12.3%) | 0.001 ** |
| Weeks 3–4 | 24.5% (17.1%) | 0.18 | 58.6% (14.0%) | 0.002 ** |
| Weeks 5–6 | 20.0% (14.4%) | 0.19 | 65.2% (15.8%) | 0.002 ** |
| Weeks 7–8 | 16.0% (23.4%) | 0.49 | 72.9% (15.9%) | 0.001 ** |
| Weeks 9–10 | 18.0% (25.2%) | 0.47 | 26.8% (12.7%) | 0.06 |
| Weeks 11–12 | 3.3% (17.6%) | 0.84 | 64.0% (18.1%) | 0.007 ** |
| % of County Strongly Hesitant of COVID-19 Vaccines | ||||
| ≤9.36% | >9.36% | |||
| Coefficient (se) | p-value | Coefficient (se) | p-value | |
| Treatment Counties × post-POV Mandate Ban periods () | ||||
| Pre-period (ref) | -- | -- | -- | -- |
| Weeks 1–2 | 10.4% (16.1%) | 0.51 | 41.5% (13.9%) | 0.016 * |
| Weeks 3–4 | 7.4% (42.0%) | 0.84 | 57.1% (16.4%) | 0.008 ** |
| Weeks 5–6 | 35.8% (49.2%) | 0.45 | 128.2% (10.8%) | <0.001 *** |
| Weeks 7–8 | 23.0% (29.0%) | 0.43 | 89.7% (19.6%) | 0.002 ** |
| Weeks 9–10 | 40.0% (27.5%) | 0.18 | 63.2% (16.9%) | 0.006 ** |
| Weeks 11–12 | 37.3% (27.5%) | 0.21 | 40.4% (16.8%) | 0.042 * |
| State | POV Mandate Ban Quotes | Legislation Type |
|---|---|---|
| AR | “(a) As used in this section, ‘vaccine passport’ means documentation that an individual has been vaccinated against coronavirus 2019 (COVID-19)”. “(b) The state, a state agency or entity, a political subdivision of the state, or a state or local official shall not require an individual to use a vaccine passport in this state for any purpose.” | SB a 615 |
| FL | “WHEREAS, requiring so-called COVID-19 vaccine passports for taking part in everyday life—such as attending a sporting event, patronizing a restaurant, or going to a movie theater—would create two classes of citizens based on vaccination…” “WHEREAS, so-called COVID-19 vaccine passports reduce individual freedom and will harm patient privacy…” “WHEREAS, it is necessary to protect the fundamental rights and privacies of Floridians and the free flow of commerce within the state.” | EO b 2021-81 |
| GA | “WHEREAS: I have determined that the following actions are necessary and appropriate to protect the individual liberty of Georgia’s residents…” | EO 5.25.21.01 |
| KS | “…no state agency named… shall expend any moneys appropriated… to (1) Issue a COVID-19 vaccination passport to any individual without the individual’s consent; (2) require an individual to use a COVID-19 vaccination passport within this state for any purpose…” | SB 159 |
| ND | “A private business located in this state may not require a patron or customer to provide any documentation certifying vaccination… to gain access to, entry upon, or services from the business.” “This section may not be construed to interfere with an individual’s rights to access that individual’s own personal health information…”. | HB c 1465 |
| SD | “Whereas, The vaccines have led to discussions of ‘vaccine passports’…used to ‘allow’ certain exercises of freedom that Americans already possess …”. “Whereas, Any rationale for imposing public health restrictions that limit freedoms should be tailored to mitigate a verifiable, scientific risk…”. “Whereas, It is improper to adopt an official government policy—a mandate—requiring widespread use of vaccine passports when such a mandate is overreaching, morally objectionable…”. | EO 2021-08 |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.
Share and Cite
Brosi, D.N.; Tung, G.; McManus, B.M.; Parinandi, S.; Mays, G.P. How Partisan Policies Can Shape Health Behaviors: Executive Order Proof-of-Vaccine Mandate Bans Increased COVID-19 Vaccinations. Vaccines 2026, 14, 486. https://doi.org/10.3390/vaccines14060486
Brosi DN, Tung G, McManus BM, Parinandi S, Mays GP. How Partisan Policies Can Shape Health Behaviors: Executive Order Proof-of-Vaccine Mandate Bans Increased COVID-19 Vaccinations. Vaccines. 2026; 14(6):486. https://doi.org/10.3390/vaccines14060486
Chicago/Turabian StyleBrosi, Deena N., Gregory Tung, Beth M. McManus, Srinivas Parinandi, and Glen P. Mays. 2026. "How Partisan Policies Can Shape Health Behaviors: Executive Order Proof-of-Vaccine Mandate Bans Increased COVID-19 Vaccinations" Vaccines 14, no. 6: 486. https://doi.org/10.3390/vaccines14060486
APA StyleBrosi, D. N., Tung, G., McManus, B. M., Parinandi, S., & Mays, G. P. (2026). How Partisan Policies Can Shape Health Behaviors: Executive Order Proof-of-Vaccine Mandate Bans Increased COVID-19 Vaccinations. Vaccines, 14(6), 486. https://doi.org/10.3390/vaccines14060486

